Professor David Price
Chair of Primary Care Respiratory Med
- 黑料网
-
- Email Address
- d.price@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437237
- School/Department
- School of Medicine, Medical Sciences and Nutrition
- Publications
-
Page 5 of 40 Results 101 to 125 of 976
Real-World Biologic Use Patterns in Severe Asthma, 2015鈥�2021: the CLEAR Study
Pragmatic and Observational Research, vol. 16, pp. 51-66Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Adopting Australian Asthma Handbook's Option A could reduce carbon footprint
TSANZSRS 2025, pp. 11-12Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
Characteristics of Asthma Patients Escalating from msICS/LABA to hsICS/LABA or msBDP/FF/G
TSANZSRS 2025, pp. 10Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
High-risk COPD patient management opportunities: Australia, US and UK comparisons
TSANZSRS 2025, pp. 19-20Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
Incidence and survival of Interstitial Lung Diseases in the UK in 2010-2019
ERJ Open Research, vol. 11, no. 2, 00823-2024Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Using routine primary care data in research: (in)efficient case studies and perspectives from the Asthma UK Centre for Applied Research
BMJ Health Care Informatics, vol. 32, no. 1, e10113Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
EUFOREA meeting on defining disease states in allergic rhinitis: towards a unified language in AR
Frontiers in Allergy, vol. 5, 1531788Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Characteristics of Patients with Asthma or Asthma-Chronic Obstructive Pulmonary Disease (COPD) Overlap Treated with Medium-Strength Inhaled Corticosteroid / Long-Acting Beta-Agonists (ICS/LABA) and Switching to High-Strength ICS/LABA or Medium-Strength Beclomethasone/Formoterol/Glycopyrronium (BDP/FF/G)
AAAAI / WAO Joint Congress 2025, pp. AB239Contributions to Journals: Abstracts- [ONLINE] DOI:
Oral Corticosteroid-Related Healthcare Resource Utilization and Associated Costs in Patients with COPD
Advances in Therapy, vol. 42, pp. 375鈥�394Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Systemic corticosteroid dose-response effects in asthma: an observational cohort study
ERJ Open Research, vol. 11, no. 1, 00172-2024Contributions to Journals: Letters- [ONLINE] DOI:
- [OPEN ACCESS]
Re 鈥淚nhaled Corticosteroid Particle Size and Risk of Hospitalization Rue to Exacerbations and All-Cause Mortality in Patients With Chronic Obstructive Respiratory Disease. A Nationwide Cohort Study鈥�. Heerfordt et al [Letter]
International journal of chronic obstructive pulmonary disease , vol. 20, pp. 243鈥�244Contributions to Journals: Letters- [ONLINE] DOI:
- [OPEN ACCESS]
Asthma Characteristics and Patient-Reported Outcomes in Patients With Atopic Dermatitis in the RAPID Registry of Dupilumab Use in a Real-World Setting
ISPOR Europe, S525Contributions to Journals: Abstracts- [ONLINE] DOI:
Characteristics of Patients With Asthma and History of Coexisting Allergic Rhinitis Initiating Dupilumab in Real-World Clinical Practice: The RAPID Registry Study
ISPOR 2024, pp. S575Contributions to Journals: Abstracts- [ONLINE] DOI:
Preserved Ratio Impaired Spirometry in US Primary Care Patients Diagnosed with Chronic Obstructive Pulmonary Disease.
Pragmatic and Observational Research, vol. 2024, no. 15, pp. 221-232Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Excess SABA prescribing in respiratory patients and social deprivation in general practice: A study of 4 million patients
ISPOR 2024, pp. S40Contributions to Journals: Abstracts- [ONLINE] DOI:
At-risk registers integrated into primary care to stop asthma crises in the UK (ARRISA-UK)
BTS Winter Meeting 2024Contributions to Conferences: AbstractsUse and acceptability of an asthma diagnosis clinical decision support system for primary care clinicians: an observational mixed methods study
npj Primary Care Respiratory Medicine, vol. 34, 40Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Do asthma patients prescribed a GLP1 have improved asthma and weight loss outcomes?
ISPOR 2024Contributions to Conferences: AbstractsDo asthma patients prescribed a GLP1 have improved asthma outcomes?
ASPR 2024Contributions to Conferences: Abstracts- [OPEN ACCESS]
COPD Treatment Pathways In Patients Initiating Dual Bronchodilators Or Triple Inhaled Therapies In A Real-World Setting
Contributions to Journals: Conference Articles- [ONLINE] DOI:
S108鈥匒t-risk registers integrated into primary care to stop asthma crises in the UK (ARRISA-UK)
Thorax, vol. 79, no. Suppl. 2, A76Contributions to Journals: Abstracts- [ONLINE] DOI:
Over-the-counter short-acting 尾2-agonist purchase and asthma-related health outcomes: a post hoc analysis of the SABINA III study
npj Primary Care Respiratory Medicine, vol. 34, no. 1, 34Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Characteristics of long-term oral corticosteroid users stratified by blood eosinophil count in the International Severe Asthma Registry
European Respiratory Society (ERS) Congress 2024, PA439Contributions to Journals: Abstracts- [ONLINE] DOI:
Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017鈥�2022: An Analysis of the International Severe Asthma Registry
Journal of Asthma and Allergy, vol. 2024, no. 17, pp. 1055-1069Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Improving the Transparency and Replicability of Consensus Methods: Respiratory Medicine as a Case Example
Pragmatic and Observational Research, vol. 2024, no. 15, pp. 201-207Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]